Out of the three molecular alterations, EGFR amplification and +7/−10 are most specific for IDH-wildtype glioblastoma, and are strong surrogate markers for the diagnosis of glioblastoma in the absence of grade 4 histologic features [96]. This evidence concerns the gene IDH2 and glioblastoma.